PRR14 Activators
PRR14 activators are a specialized class of molecules that engage with the Proline-Rich 14 (PRR14) protein, which is known to have a role in cellular processes involving protein-protein interactions due to its proline-rich domain. The PRR14 protein's exact physiological functions remain not fully elucidated, but it is understood that the modulation of its activity can have significant effects on the cellular mechanisms in which it is involved. PRR14 activators are therefore designed to bind to this protein and enhance its natural activity. The activators might achieve this by stabilizing the protein in an active conformation, facilitating its interaction with other proteins, or by preventing its degradation. The development of such activators requires intricate knowledge of the structure and function of PRR14, particularly the regions of the protein that are amenable to binding by small molecules or other types of ligands.
The synthesis and discovery of PRR14 activators involve a combination of computational and experimental methods. Initially, computational biology tools such as molecular docking and dynamic simulation are often used to predict the interaction between activators and the PRR14 protein. These predictions are then tested in the laboratory, where synthesized compounds are subjected to various assays to confirm their ability to bind to and activate PRR14. High-throughput screening techniques may be employed to identify promising activator candidates from vast libraries of compounds. Following the identification of activators, further chemical modification and optimization are carried out to improve the affinity, specificity, and overall efficacy of these compounds. Such optimization is guided by detailed structure-activity relationships (SAR) analysis, which provides insights into how different chemical modifications affect the interaction with PRR14. The goal of this meticulous research process is to produce a set of compounds that are capable of specifically targeting PRR14 and modulating its function in the desired manner, thereby contributing to the understanding of the protein's role in cellular dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can activate PKA. PKA then phosphorylates target proteins, potentially including PRR14, which could enhance PRR14's role in chromatin organization and nuclear architecture maintenance. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP acts as a cAMP analog, increasing PKA activity. PKA can modulate chromatin structure through phosphorylation events, which may indirectly promote PRR14's involvement in the organization of heterochromatin. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX increases cAMP levels by inhibiting phosphodiesterases, leading to PKA activation. Activated PKA could then facilitate PRR14 function by phosphorylating proteins that interact with or regulate PRR14 activity within the nucleus. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which is involved in intracellular signaling. PKC activation could lead to modifications in the chromatin environment, thus enhancing the structural role of PRR14 in nuclear architecture. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent kinases. These kinases could phosphorylate regulatory proteins that affect PRR14’s function in chromatin dynamics and nuclear integrity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation status within the cell. This could contribute to the activation of pathways that stabilize or enhance PRR14's interactions with chromatin. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases could indirectly increase the phosphorylation of proteins that modulate the activity of PRR14 in nuclear processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), leading to a more open chromatin state. This could facilitate PRR14’s role in chromatin remodeling by allowing better access or binding to chromatin. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is an HDAC inhibitor that allows for increased acetylation of histones, potentially enhancing the chromatin-related functions of PRR14 by promoting a relaxed chromatin state. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that leads to hypomethylation of DNA, which could indirectly support PRR14’s role in maintaining nuclear architecture by affecting chromatin structure. | ||||||